Literature DB >> 22748829

Environmental conditions modulate neurotoxic effects of psychomotor stimulant drugs of abuse.

Eugene A Kiyatkin1, Hari Shanker Sharma.   

Abstract

Psychomotor stimulants such as methamphetamine (METH), amphetamine, and 3,4-metylenedioxymethamphetamine (MDMA or ecstasy) are potent addictive drugs. While it is known that their abuse could result in adverse health complications, including neurotoxicity, both the environmental conditions and activity states associated with their intake could strongly enhance drug toxicity, often resulting in life-threatening health complications. In this review, we analyze results of animal experiments that suggest that even moderate increases in environmental temperatures and physiological activation, the conditions typical of human raves parties, dramatically potentiate brain hyperthermic effects of METH and MDMA. We demonstrate that METH also induces breakdown of the blood-brain barrier, acute glial activation, brain edema, and structural abnormalities of various subtypes of brain cells; these effects are also strongly enhanced when the drug is used at moderately warm environmental conditions. We consider the mechanisms underlying environmental modulation of acute drug neurotoxicity and focus on the role of brain temperature, a critical homeostatic parameter that could be affected by metabolism-enhancing drugs and environmental conditions and affect neural activity and functions.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22748829      PMCID: PMC3687356          DOI: 10.1016/B978-0-12-386986-9.00006-5

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  72 in total

1.  Effect of reduced flow on blood-brain barrier transport systems.

Authors:  S Hom; R D Egleton; J D Huber; T P Davis
Journal:  Brain Res       Date:  2001-01-26       Impact factor: 3.252

2.  Involvement of free radicals in MDMA-induced neurotoxicity in mice.

Authors:  J L Cadet; N Thiriet; S Jayanthi
Journal:  Ann Med Interne (Paris)       Date:  2001-04

3.  Brain and body hyperthermia associated with heroin self-administration in rats.

Authors:  Eugene A Kiyatkin; Roy A Wise
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

4.  Rapid astrocyte death induced by transient hypoxia, acidosis, and extracellular ion shifts.

Authors:  A Bondarenko; M Chesler
Journal:  Glia       Date:  2001-04-15       Impact factor: 7.452

Review 5.  Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid.

Authors:  I Lutsar; I R Friedland
Journal:  Clin Pharmacokinet       Date:  2000-11       Impact factor: 6.447

6.  Methamphetamine decreases mouse striatal dopamine transporter activity: roles of hyperthermia and dopamine.

Authors:  V Sandoval; G R Hanson; A E Fleckenstein
Journal:  Eur J Pharmacol       Date:  2000-12-15       Impact factor: 4.432

Review 7.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

8.  Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.

Authors:  P Esposito; D Gheorghe; K Kandere; X Pang; R Connolly; S Jacobson; T C Theoharides
Journal:  Brain Res       Date:  2001-01-05       Impact factor: 3.252

9.  Evaluation of the effect of stress on the blood--brain barrier: critical role of the brain perfusion time.

Authors:  H Ovadia; O Abramsky; S Feldman; J Weidenfeld
Journal:  Brain Res       Date:  2001-06-29       Impact factor: 3.252

10.  Selected contribution: ambient temperature for experiments in rats: a new method for determining the zone of thermal neutrality.

Authors:  Andrej A Romanovsky; Andrei I Ivanov; Yury P Shimansky
Journal:  J Appl Physiol (1985)       Date:  2002-06
View more
  8 in total

1.  Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes.

Authors:  Irma E Cisneros; Anuja Ghorpade
Journal:  Neuropharmacology       Date:  2014-06-17       Impact factor: 5.250

2.  Not just the brain: methamphetamine disrupts blood-spinal cord barrier and induces acute glial activation and structural damage of spinal cord cells.

Authors:  Eugene A Kiyatkin; Hari S Sharma
Journal:  CNS Neurol Disord Drug Targets       Date:  2015       Impact factor: 4.388

3.  Exacerbation of Methamphetamine Neurotoxicity in Cold and Hot Environments: Neuroprotective Effects of an Antioxidant Compound H-290/51.

Authors:  Hari Shanker Sharma; Eugene A Kiyatkin; Ranjana Patnaik; José Vicente Lafuente; Dafin F Muresanu; Per-Ove Sjöquist; Aruna Sharma
Journal:  Mol Neurobiol       Date:  2015-06-26       Impact factor: 5.590

4.  Amphetamine withdrawal differentially affects hippocampal and peripheral corticosterone levels in response to stress.

Authors:  Brenna Bray; Jamie L Scholl; Wenyu Tu; Michael J Watt; Kenneth J Renner; Gina L Forster
Journal:  Brain Res       Date:  2016-05-18       Impact factor: 3.252

5.  High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone.

Authors:  Yu Chen; Huyen T N Tran; Yasir H Saber; F Scott Hall
Journal:  Pharmacol Biochem Behav       Date:  2020-03-19       Impact factor: 3.533

Review 6.  Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia.

Authors:  Rae R Matsumoto; Michael J Seminerio; Ryan C Turner; Matthew J Robson; Linda Nguyen; Diane B Miller; James P O'Callaghan
Journal:  Pharmacol Ther       Date:  2014-05-14       Impact factor: 12.310

Review 7.  Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology.

Authors:  Shaobin Yu; Ling Zhu; Qiang Shen; Xue Bai; Xuhui Di
Journal:  Behav Neurol       Date:  2015-03-12       Impact factor: 3.342

8.  Heat remains unaccounted for in thermal physiology and climate change research.

Authors:  Andreas D Flouris; Glen P Kenny
Journal:  F1000Res       Date:  2017-03-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.